Background: Human dental mesenchymal stem cells (MSCs) are considered as highly accessible and attractive MSCs for use in regenerative medicine, yet some of their features are not as well characterized as in other MSCs. Hypoxia-preconditioning and hypoxia inducible factor 1 alpha (HIF-1 alpha) overexpression significantly improve MSC therapeutics, but the mechanisms involved are not fully understood. In the present study, we characterize immunomodulatory properties of dental MSCs and determine changes in their ability to modulate adaptive and innate immune populations after HIF-1 alpha overexpression.
Background
Among different sources of MSCs, dental MSCs (dental pulp, periodontal ligament, apical papilla, dental follicle and gingival tissue) are currently considered as one of the most attractive MSCs for use in engineering tissue and regenerative medicine. Great advantages presented by dental MSCs include accessibility, easy in vitro expansion, low immunogenicity and ability to differentiate into mesodermderived tissues [1] . Low frequency of in vivo differentiation of transplanted MSCs in experimental models [2] [3] [4] [5] indicates that MSCs promote tissue repair through paracrine modulation of surrounding cells. Cell populations normally targeted by MSCs include resident progenitor cells, endothelial cells and immune cells [6] .
Many efforts are currently focused on furthering the therapeutic potential of MSCs. In this regard, we and others have previously demonstrated that hypoxia and, more specifically, overexpression of hypoxia-inducible factor-1 (HIF-1) by genetic engineering potentiates the therapeutic properties of MSCs [7] . Owing to the critical role that the immune response plays in most of the pathologies targeted by MSC therapy, a better understanding of the effects of hypoxia over the immunomodulatory capacity of MSCs is of great importance.
In the present study, we present a comprehensive characterization of the in vitro immunomodulatory properties and expression of immune and trophic factors in dental MSCs. Besides, we demonstrate that overexpression of HIF-1 alpha improves several of these features, enhancing also their resistance to NK cell-lytic activity.
Methods
All procedures were approved by the Instituto de Salud Carlos III and institutional Ethical and Animal Care Committees.
Vector production, lentiviral transduction and mesenchymal stem cells culture
MSCs from human dental pulp were expanded as described [8] and transduced with lentiviral vectors pWP-GFP (MSCs) or pWP-HIF-GFP (HIF-MSCs) as described [7] . Percentages of infection obtained were normally around 90%. Human dental pulp MSCs (n=3; Inbiobank) were cultured in DMEM low glucose (Sigma-Aldrich Spain) supplemented with 10% heat-inactivated fetal calf serum (FCS) (Gibco, Life Technologies, Thermo Fisher Scientific). Cells were grown until confluence and subsequently subcultured up to 12 passages. For stimulation assays, 5x10 4 MSCs were seeded in 6-well flat-bottom culture plates and after 3 days, media were replenished and supplemented or not with 10 ng/ml of rhIFN-gamma (Invitrogen). After 15 hours, cells were lysed for subsequent analysis by quantitative-PCR (qPCR).
Seahorse extracellular metabolic-flux assays
The Seahorse extracellular flux analyzer XFp (Seahorse Bioscience) was used to perform the Mitochondrial and Glycolysis Stress Tests. Detailed conditions in supplementary material.
Mitochondrial Stress Test: four basal oxygen consumption rate (OCR) measurements were taken. Subsequently, mitochondrial membrane modulators oligomycin (1 µM), followed by FCCP (1 µM) and lastly antimycin A/rotenone (both 1 µM) were injected (four measuring cycles each). Basal respiration, ATP production, maximal respiration, spare respiratory capacity and proton leak were defined by the differences between average measurements 4-16, 4-8, 12-16, 4-9 and 8-16, respectively. Non-mitochondrial respiration was defined by average measurement 16.
Glycolysis Stress Test: the extracellular acidification rate (ECAR) measurements were taken. Subsequently, glucose (10 mM), followed by oligomycin (1 µM) and 2-deoxy-glucose (2-DG, 100 mM) were injected (four measuring cycles each).
Basal glycolysis, glycolytic capacity and glycolytic reserve were calculated by the differences between average measurements 4-8, 12-16, 8-12, respectively. Nonglycolytic acidification was defined by average measurement 16.
In both assays, total protein per well was quantified with the BCA Protein Assay Kit for normalization.
Isolation and culture of human blood cells
Buffy coats of healthy donors were obtained after informed consent (Centro de Transfusión de la Comunidad de Madrid, Spain) and peripheral blood mononuclear cells (PBMCs) were isolated by density gradient centrifugation with Lymphocyte Isolation Solution (Rafer). Monocytes and NK cells were isolated by positive and negative magnetic separation (MiltenyiBiotec). Non-adherent T lymphocyte-enriched cell suspensions were obtained by nylon wool purification. Percentage of CD3 + cells was always above 85%. Table 2 for a list of antibodies used. Immunofluorescence staining was performed as described [9] . For intracellular staining, brefeldin A (BioLegend) was added for the final 4 hours of culture and cells were treated with Fixation/Permeabilization Solution Kit (BD Biosciences). All flow cytometry analyses were conducted in a FACSCalibur flow cytometer (BD Biosciences) from the Centro de Citometría y Microscopía de Fluorescencia, Complutense University of Madrid.
Flow cytometry

See Supplementary
Proliferation assays
Before culture, T lymphocyte-enriched cell suspensions were labeled with 5µM CFSE (BioLegend). Proliferation of T cells (CD3 + /CD4 + and CD3 + /CD8 + ) was determined after 4 days by the CFSE dilution method. T cells were gated according to forward and side scatter.
Apoptosis assays
The proportion of apoptotic MSCs was determined by incorporation of propidium iodide. MSC death was calculated as percentage of CD90 + /propidium iodide + cells. Table 2 ). All PCR reactions were set in duplicates using the TaqMan Gene Expression Master Mix (Applied Biosystems). Amplifications, detections, and analyses were performed in a 7.900HT Fast Real-time PCR System (Centro de Genómica, Complutense University, Madrid, Spain). The Delta CT method was used for normalization to GNB2L1 mRNA.
Migration assays
Cytokine measurements
Levels of IFN gamma (R&D Systems), TNF-alpha and IL-10 in culture supernatants were assayed by ELISA (BioLegend). Production of CCL2/MCP-1 was measured by cytometric bead array (CBA, BD Biosciences).
MM = (Nº CD14 + cells with MSCs) -(Nº CD14 + cells without
MSCs)
x 100
Nº CD14 + cells without MSCs
Statistical analysis
Student t test was used. Values of p≤0.05 (*/#) and p≤0.01 (**/##) were considered to be statistically significant.
Results
Efficient transduction of functionally active HIF-1 alpha in dental MSCs
MSCs from dental pulp were expanded and transduced with the lentiviral vectors pWP- 
Effects of HIF-1 alpha overexpression in the modulation of the adaptive immune response by dental MSCs
T cells and DCs are main players in adaptive immunity, with T cells acting as main effectors when a deleterious inflammatory response is developed. In addition, impairment of T cell response is a well-established feature of MSCs [10, 11] . As a first approach, we investigated the impact of HIF-1 alpha expression on the ability of MSCs to inhibit TCR-triggered activation of T cells. When T cells were activated in the presence of MSCs, proliferation of both CD4 + and CD8 + T cells was dramatically reduced, regardless HIF-1 alpha overexpression by MSCs ( figure 2A and 2B ). As 
Overexpression of HIF-1 alpha by MSCs increases recruitment of monocytes which acquire immunosuppressive properties
Generation of pro-inflammatory macrophages from blood monocytes in response to environmental factors is a key phenomenon in the development of inflammation and tissue damage [12] . Our results show that the majority of monocytes cultured with both types of MSCs exhibited a CD14 high /CD163 high phenotype ( figure 4A and 4B ). This phenotype has been previously associated to suppressor or M2 features in macrophages [13] . In this line, we found that the production of TNF-alpha was severely impaired by the presence of both MSCs and HIF-MSCs while IL-10 levels were remarkably increased in these co-cultures ( figure 4C) .
These results suggested that the recruitment of monocytes to the site of inflammation could be advantageous in patients transplanted with dental MSCs. In this regard, CCL2/MCP-1 is the main chemokine driving monocyte extravasation. We were cultured with rhGM-CSF to induce macrophage differentiation. After seven days, expression of CD14 and CD163 was determined by flow cytometry. A representative experiment (A) and mean ± SD of three independent experiments (B) are shown. MSCs were excluded from the analysis by CD90 expression. C) After 7 days of culture, LPS was added for 24 hours and supernatants were assayed for TNF alpha and IL-10 production. Data are presented as mean ± SD of three independent experiments. (* p≤0.05; MSCs and HIF-MSCs vs No MSCs). D and E) MSCs were cultured until 80% confluence, then fresh medium alone (Med) or supplemented with IFN gamma (IFN) was added. After 15 hour cells and supernatants were harvested. Transcript (D) and protein levels (E) for CCL2 were determined by quantitative PCR and CBA respectively. GNB2L1 was used as endogenous control. Mean ± SD of four samples pooled from two independent experiments is shown. (* p≤0.05; MSCs vs HIF-MSCs). F) Transwell (8 µm) cultures were performed as stated in the materials and methods section. After 14 hours, migrated cells (present at the lower chamber) were collected and stained for CD14. MSCs were excluded from the analysis by CD90 expression and monocytes were gated according to forward/side scatter characteristics and expression of CD14, and counted in a FACSCalibur flow cytometer.
HIF-1 alpha overexpression confers resistance to NK cell-mediated lysis
Poor mid-term persistence of transplanted MSCs limits the therapeutic impact of MSCs, most notably in myocardial infarction cell therapy [14] . NK cells have been postulated as key mediators in this process, since they efficiently lyse autologous and allogeneic MSCs, participating in the clearance of these cells after transplantation, also accompanied by IFN gamma secretion [15] . Consistent with the literature, we found that degranulation of activated NK cells was increased in the presence of dental MSCs ( figure 5A ). Nevertheless, in HIF-MSC co-cultures NK cell degranulation was significantly impaired. In accordance, HIF-MSCs exhibited a marked resistance to NK cell-mediated death ( figure 5B ). Also importantly, increased IFN-gamma production by NK cells was strongly reduced by HIF-MSCs ( figure 5C ).
Interestingly, increased resistance of HIF-MSCs to NK cell-mediated lysis was not associated to differential modulation of the NK cell effector molecules granzyme B and perforin ( figure 5D ). Activation of the receptors Natural Killer Group 2D (NKG2D) and NKp30 has been shown to be critical for optimal lysis of MSCs by activated NK cells [15] . Nevertheless, we found no differences in the expression of NKG2D and NKp30 between NK cells activated in the presence of MSCs or HIF-MSCs ( figure 5D ). On the other hand, analysis of the expression by MSCs of the ligands for these NK cell activating receptor revealed a reduction in the basal expression of ULBP1 and B7H6 in HIF-MSCs ( figure 5E ). These dissimilarities were strengthened after stimulation with IFN-gamma, a pro-inflammatory factor highly produced by activated NK cells, again with a reduced expression of ULBP1, B7H6 and ULBP2 on HIF-MSCs ( figure 5F ). 
Enhanced immunosuppressive and pro-angiogenic features in HIF-1 alpha expressing MSCs
Following, we analyzed the expression of relevant factors regulating inflammation and tissue remodeling. Figure 6A represents the expression of immunomodulatory factors in control dental MSCs at basal levels and after IFN-gamma stimulation. As shown in the figure, IFN-gamma induced in MSCs the expression of TLR3, TLR4, IL6 and, to a lesser extent, COX2. On the contrary, LGALS1, encoding for galectin 1, was greatly expressed by dental MSCs but not induced after IFN-gamma stimulation ( figure 6A ).
Comparative analysis showed enhanced basal expression of the immunosuppressive molecules galectin 1 and IL-6 in HIF-MSCs ( figure 6B, left panel) . In an inflammatory context, mimicked by IFN-gamma stimulation, HIF-MSCs maintained a higher expression of IL6 ( figure 6B, right panel) .
We found also that dental MSCs differentially expressed a number of proangiogenic and trophic factors of which only CXCL10 showed strong induction after IFN gamma treatment ( figure 6C ). Expression of CXCL12 and CCL5 was higher in HIF-MSCs both at basal levels and after addition of IFN-gamma, while the basal transcription of the pro-fibrotic factor TGFB1 was reduced (figure 6D, left and right panels). Remarkably, overexpression of HIF-1 alpha caused a complete loss of 
Discussion
Dental MSC-based cell therapy is currently under extensive research in a wide range of pathologies in which inflammation plays a key role. These include wound healing, spinal cord injury and periodontitis [2, 16, 17] . While suppressor activities through T cell and macrophage responses have been previously described [18] , the role of dental MSCs cells in multiple immune interactions remains elusive.
Our results show that inhibition of CD4 + and CD8 + T cell responses to TCR stimulation by dental MSCs is independent of HIF-1 alpha expression. This might be correlated with the lack of differences in the expression of COX2/PGE2, IL-10, and IDO (figure 5 and data not shown), main factors driving T cell inhibition by dental MSCs [19, 20] . Recently, it was demonstrated that inhibition of proliferation of PBMCs by gingiva MSCs is increased after hypoxia preconditioning, with the participation of IL-10 and FasL [21] . Since total PBMCs were used in this experiments, it is difficult to know whether T cells were directly targeted by hypoxic gingiva MSCs. Accordingly, inhibition of T cell proliferation by adipose tissue-derived MSCs is not altered under hypoxic conditions [22] .
On the other hand, we found that HIF-1 alpha overexpression induces higher expression IL6, a known negative regulator of DC differentiation and function [23, 24] .
Enhanced expression of IL6 has also been shown in hypoxia-conditioned MSCs from bone marrow [25] . This could explain that impairment of DC differentiation by dental MSCs is more efficient when MSCs express HIF-1 alpha.
We also discovered that HIF-MSCs produce higher levels of the chemokine CCL2/MCP1 under inflammatory conditions and promote greater attraction of monocytes. This is in agreement with recent data showing that conditioned medium from hypoxic bone marrow-derived MSCs enhances monocyte migration and recruitment of F4/80 + macrophages during wound healing [25] . Recent reports show that dental MSCs induces suppressor macrophage differentiation with the participation of different factors including IL-6 and CCL2/MCP-1 [17, 26] . Furthermore, we present here that monocytes cultured with dental MSCs exhibit high IL-10 and low TNF-alpha production after LPS/TLR-4 stimulation. It is important to note that TLR-4 agonists are normally present after tissue damage [27] . Owing to the beneficial role normally attributed to anti-inflammatory macrophages [28] , we propose that expression of HIF-1 alpha by MSCs would be advantageous for the resolution of inflammation through enhanced recruitment and differentiation of suppressor macrophages. NK cell-mediated lysis of MSCs might be linked to the poor mid-term persistence of transplanted MSCs observed in vivo [14, 15, 29] . Here, we confirm these observations showing that NK cells are capable of killing dental MSCs, along with increased production of IFN gamma. Nevertheless, HIF-MSCs exhibit increased resistance to NK cell-mediated lysis as shown by reduced MSC cell death, NK cell degranulation and IFN gamma production. Efficient NK cell-mediated lysis requires binding of the activating receptors expressed on NK cells, to their natural ligands, expressed in MSCs [15] . Consistently, we show that HIF-MSCs exhibit a significantly reduced expression of the NK cell activating receptor ligands ULBP1 and B7H6 [30] .
Interestingly, this mechanism is frequently exploited by tumor cells [31] [32] [33] . These results are coherent with the increased engraftment and survival of hypoxia-conditioned MSCs after transplantation [34, 35] . Considering that poor mid-term persistence of transplanted MSCs is a limiting factor for the therapeutic potential of MSCs [14] , we provide here evidences which support that HIF-1 alpha expression could be a useful approach to overcome this limitation.
MSCs may exert tissue repair and regeneration through paracrine factors, acting on surrounding cells and directing cytoprotection and neovascularization [6] . We have found that HIF-MSCs exhibit enhanced expression of CXCL12/SDF1 and CCL5/RANTES, factors widely known by their pro-angiogenic actions [36, 37] . Strikingly, our results demonstrate that HIF-1 alpha expression in MSCs completely abrogates CXCL10/IP10 expression. This factor can limit new vessel growth by inhibiting endothelial cell migration, and can induce involution of new vessels [38] .
Similarly, enhanced angiogenic potential of hypoxia-conditioned MSCs has been shown in two different experimental models for ischemia [34, 39] .
Conclusions
Hypoxia-preconditioning of MSCs significantly improves the therapeutics of MSCs. Furthermore, this procedure has been suggested for standardized protocols of MSC preparation for clinical applications [40] . The present work demonstrates that HIF-1 alpha overexpression confers to MSCs enhanced paracrine capacities which might participate in the previously described benefits of HIF-MSC therapy after myocardial infarction [7] . Furthermore, HIF-MSCs exhibit increased resistance to NK cell-mediated lysis, which will help to prolong their lifespan in the host. We believe that dental MSCs and genetic engineering to express HIF-1 alpha are powerful tools for furthering the therapeutic potential of cell therapy.
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